88 related articles for article (PubMed ID: 17382702)
1. Interferon-alpha resistance associated genes in renal cell carcinoma identified by expression profiling.
Korkola JE; Kondagunta GV; Reuter VE; Motzer RJ; Chaganti RS
J Urol; 2007 Apr; 177(4):1264-8; discussion 1268. PubMed ID: 17382702
[TBL] [Abstract][Full Text] [Related]
2. Low expression of microphthalmia-associated transcription factor, a potential molecular target for interferon-alpha susceptibility, is associated with metastasis in renal cell carcinoma.
Shimazui T; Kojima T; Yoshikawa K; Ami Y; Oikawa T; Uchida K; Akaza H
Cancer Sci; 2009 Sep; 100(9):1714-8. PubMed ID: 19496784
[TBL] [Abstract][Full Text] [Related]
3. Gene signatures of progression and metastasis in renal cell cancer.
Jones J; Otu H; Spentzos D; Kolia S; Inan M; Beecken WD; Fellbaum C; Gu X; Joseph M; Pantuck AJ; Jonas D; Libermann TA
Clin Cancer Res; 2005 Aug; 11(16):5730-9. PubMed ID: 16115910
[TBL] [Abstract][Full Text] [Related]
4. STAT3 polymorphism predicts interferon-alfa response in patients with metastatic renal cell carcinoma.
Ito N; Eto M; Nakamura E; Takahashi A; Tsukamoto T; Toma H; Nakazawa H; Hirao Y; Uemura H; Kagawa S; Kanayama H; Nose Y; Kinukawa N; Nakamura T; Jinnai N; Seki T; Takamatsu M; Masui Y; Naito S; Ogawa O
J Clin Oncol; 2007 Jul; 25(19):2785-91. PubMed ID: 17602083
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling of renal cell carcinoma: a DNA macroarray analysis.
Lovisolo JA; Casati B; Clerici L; Marafante E; Bono AV; Celato N; Salvadore M
BJU Int; 2006 Jul; 98(1):205-16. PubMed ID: 16831170
[TBL] [Abstract][Full Text] [Related]
6. Comparative transcriptional and functional profiling of clear cell and papillary renal cell carcinoma.
Diegmann J; Tomiuk S; Sanjmyatav J; Junker K; Hindermann W; von Eggeling F
Int J Mol Med; 2006 Sep; 18(3):395-403. PubMed ID: 16865223
[TBL] [Abstract][Full Text] [Related]
7. Prediction of response to combined immunotherapy with interferon-alpha and low-dose interleukin-2 in metastatic renal cell carcinoma: expression patterns of potential molecular markers in radical nephrectomy specimens.
Miyake H; Sakai I; Muramaki M; Kurahashi T; Takenaka A; Fujisawa M
Int J Urol; 2009 May; 16(5):465-71. PubMed ID: 19467119
[TBL] [Abstract][Full Text] [Related]
8. In search of suitable reference genes for gene expression studies of human renal cell carcinoma by real-time PCR.
Jung M; Ramankulov A; Roigas J; Johannsen M; Ringsdorf M; Kristiansen G; Jung K
BMC Mol Biol; 2007 Jun; 8():47. PubMed ID: 17559644
[TBL] [Abstract][Full Text] [Related]
9. Differential gene expression identifies subgroups of renal cell carcinoma.
Skubitz KM; Zimmermann W; Kammerer R; Pambuccian S; Skubitz AP
J Lab Clin Med; 2006 May; 147(5):250-67. PubMed ID: 16697773
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling of renal medullary carcinoma: potential clinical relevance.
Yang XJ; Sugimura J; Tretiakova MS; Furge K; Zagaja G; Sokoloff M; Pins M; Bergan R; Grignon DJ; Stadler WM; Vogelzang NJ; Teh BT
Cancer; 2004 Mar; 100(5):976-85. PubMed ID: 14983493
[TBL] [Abstract][Full Text] [Related]
11. mRNA expression profiles of methylated APAF-1 and DAPK-1 tumor suppressor genes uncover clear cell renal cell carcinomas with aggressive phenotype.
Christoph F; Hinz S; Kempkensteffen C; Schostak M; Schrader M; Miller K
J Urol; 2007 Dec; 178(6):2655-9. PubMed ID: 17945286
[TBL] [Abstract][Full Text] [Related]
12. Resistance to the tubulin-binding agents in renal cell carcinoma: no mutations in the class I beta-tubulin gene but changes in tubulin isotype protein expression.
Ferguson RE; Taylor C; Stanley A; Butler E; Joyce A; Harnden P; Patel PM; Selby PJ; Banks RE
Clin Cancer Res; 2005 May; 11(9):3439-45. PubMed ID: 15867246
[TBL] [Abstract][Full Text] [Related]
13. Defective Jak-Stat activation in renal cell carcinoma is associated with interferon-alpha resistance.
Shang D; Liu Y; Ito N; Kamoto T; Ogawa O
Cancer Sci; 2007 Aug; 98(8):1259-64. PubMed ID: 17573897
[TBL] [Abstract][Full Text] [Related]
14. Psoralen plus ultraviolet A +/- interferon-alpha treatment resistance in mycosis fungoides: the role of tumour microenvironment, nuclear transcription factor-kappaB and T-cell receptor pathways.
Wozniak MB; Tracey L; Ortiz-Romero PL; Montes S; Alvarez M; Fraga J; Fernández Herrera J; Vidal S; Rodriguez-Peralto JL; Piris MA; Villuendas Deceased R
Br J Dermatol; 2009 Jan; 160(1):92-102. PubMed ID: 18945306
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel epigenetic markers for clear cell renal cell carcinoma.
Dalgin GS; Drever M; Williams T; King T; DeLisi C; Liou LS
J Urol; 2008 Sep; 180(3):1126-30. PubMed ID: 18639284
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes.
Kauffman EC; Barocas DA; Chen YT; Yang XJ; Scherr DS; Tu JJ
J Urol; 2009 May; 181(5):2305-11. PubMed ID: 19303095
[TBL] [Abstract][Full Text] [Related]
17. Significance of gene expression analysis of renal cell carcinoma.
Leppert JT; Pantuck AJ
Expert Rev Anticancer Ther; 2006 Feb; 6(2):293-9. PubMed ID: 16445381
[TBL] [Abstract][Full Text] [Related]
18. The sensitivity of renal cell carcinoma cells to interferon alpha correlates with p53-induction and involves Bax.
Wittnebel S; Jalil A; Thiery J; DaRocha S; Viey E; Escudier B; Chouaib S; Caignard A
Eur Cytokine Netw; 2005 Jun; 16(2):123-7. PubMed ID: 15941683
[TBL] [Abstract][Full Text] [Related]
19. Identification of deregulated oncogenic pathways in renal cell carcinoma: an integrated oncogenomic approach based on gene expression profiling.
Furge KA; Tan MH; Dykema K; Kort E; Stadler W; Yao X; Zhou M; Teh BT
Oncogene; 2007 Feb; 26(9):1346-50. PubMed ID: 17322920
[TBL] [Abstract][Full Text] [Related]
20. [DNA and microRNA microarray technologies in diagnostics and prediction for patients with renal cell carcinoma].
Slabý O; Svoboda M; Michálek J; Vyzula R
Klin Onkol; 2009; 22(5):202-9. PubMed ID: 19886357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
